Webinars: Catalysts for Family Office Collaboration in 2026
Explore how webinars are transforming engagement for family offices in 2026.

PYC is using its expertise in RNA drug design and proprietary drug delivery technology to bring a powerful new class of precision medicine to patients. With an initial focus on rare eye disease, PYC’s technology has the potential to unlock treatments for multiple types of genetic disease.
The company has proven the efficacy and safety of its lead drug program in patient-derived models and has launched formal studies in preparation for human clinical trials in 2021.

Explore how webinars are transforming engagement for family offices in 2026.

Explore how webinars enhance engagement and knowledge sharing in family offices.

Explore how webinars are reshaping engagement strategies for family offices in 2026, enhancing collaboration and knowledge sharing.
Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.
Join the discussion
Comments are open to signed-in members. Sign in to add yours, or apply to join the network.
Sign in Apply for FON+